Women's formula
Natural health product licensed in Canada
- Licence holder
- Canadian Phytopharmaceuticals Corporation
- NPN or DIN-HM
- 80058717
- Status
- Active licence
- Licence date
- 5 March 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lycium barbarum Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 360 milligramme | 36 milligramme | Not calculated |
| Epimedium brevicornu Source : Feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 720 milligramme | 72 milligramme | Not calculated |
| Angelica sinensis Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 720 milligramme | 72 milligramme | Not calculated |
| Carthamus tinctorius Source : Fleur Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 720 milligramme | 72 milligramme | Not calculated |
| Panax quinquefolius Source : Fleur Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 720 milligramme | 72 milligramme | Not calculated |
| Wolfiporia extensa Source : Sclerotium Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 765 milligramme | 76.5 milligramme | Not calculated |
| Extrait d'isoflavone de soja Source : Extrait d'isoflavone de soja Potency : 12.09 % Genistein | 20 milligramme | Not calculated |
| Extrait d'isoflavone de soja Source : Extrait d'isoflavone de soja Potency : 43.86 % Isoflavones | Not specified | Not calculated |
| Leonurus japonicus Source : Plante | 10 milligramme | Not calculated |
| Actaea racemosa Source : Rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 50 milligramme | 5 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes ménopausées et en postménopause | Not specified | minimum: 1 Capsule ; maximum: 3 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve symptoms associated with menopause, to help relieve the pain associated with menstruation and to help ease nervous tension.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are breastfeeding. Consult a health care practitioner prior to use if you have a liver disorder or develop symptoms of liver trouble. If you have a yin deficiency, sunken Spleen qi, or cold from deficiency with spermatorrhea, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking blood thinners, digoxin or anticoagulants. Consult a health care practitioner prior to use if you have diabetes. If menstruation is delayed or absent, or if you experience increased menstrual bleeding time, discontinue use and consult a health care practitioner. If you are taking birth control pills or hormone replacement therapy (HRT), consult a health care practitioner prior to use. Consult a health care practitioner if symptoms persist or worsen. Ensure you are up-to-date on mammograms and gynaecological evaluations prior to use. Consult a health care practitioner prior to use if you have a history of hormonal or gynaecological disease, including ovarian cancer, endometriosis, and/or uterine fibroids. Discontinue use and consult a health care practitioner if you experience breast pain, discomfort and/or tenderness, or if you experience a recurrence of menstruation and/or uterine spotting.
- Contre-indications
If you have hypermenorrhoea/ profuse menstrual flow/ heavy periods, do not use this product. If you have diarrhoea or haemorrhagic diseases, do not use this product. If you have allergy/hypersensitivity to members of the Apiaceae/Umbelliferae family (anise, caraway, carrot, celery, dill, parsley), do not use this product. If you are pregnant, do not use this product. Do not use if you currently have or previously had breast cancer and/or breast tumours or if you have a predisposition to breast cancer, as indicated by an abnormal mammogram and/or biopsy, or a family member with breast cancer.
Source
Official Health Canada record, licence 80058717
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.